Cingulate Inc (CING)

07:57 AM

Cingulate stock price target raised to $20 at H.C. Wainwright By Investing.com - Investing.com South Africa

07:57 AM

07:55 AM

Cingulate stock price target raised to $20 at H.C. Wainwright - Investing.com India

07:55 AM

07:38 AM

Meta Platforms To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga

07:38 AM

Jan 29, 2025

Public company CEO concludes case alleging aggravated domestic battery - The Business Journals

Jan 29, 2025

Jan 25, 2025

Cingulate Inc. adjusts executive compensation - Investing.com India

Jan 25, 2025

Jan 24, 2025

Cingulate Inc. adjusts executive compensation By Investing.com - Investing.com UK

Jan 24, 2025

Jan 15, 2025

Jane Street Group LLC Invests $106,000 in Cingulate Inc. (NASDAQ:CING) - Defense World

Jan 15, 2025

Jan 12, 2025

Cingulate stock rated Buy by Roth/MKM, anticipates $1.6B sales potential - Investing.com Canada

Jan 12, 2025

Jan 12, 2025

Cingulate (NASDAQ:CING) Coverage Initiated at Roth Mkm - Defense World

Jan 12, 2025

Jan 12, 2025

Roth Capital Upgrades Cingulate (NASDAQ:CING) to “Strong-Buy” - Defense World

Jan 12, 2025

Jan 10, 2025

Roth MKM Initiates Coverage of Cingulate (CING) with Buy Recommendation - MSN

Jan 10, 2025

Jan 07, 2025

CINGWCingulate Inc. Warrants Latest Stock News & Market Updates - StockTitan

Jan 07, 2025

Jan 07, 2025

Cingulate Inc Completes Key FDA Study for ADHD Drug - TipRanks

Jan 07, 2025

Jan 07, 2025

Final Study Completed for Cingulate’s Lead Asset CTx-1301 - GlobeNewswire

Jan 07, 2025

Jan 07, 2025

Cingulate Completes Final FDA Study for Once-Daily ADHD Drug CTx-1301 with Zero Safety Issues - StockTitan

Jan 07, 2025

Dec 26, 2024

Cingulate Inc. Enters into Note Purchase Agreement with Streeterville Capital, LLC - Defense World

Dec 26, 2024

Dec 24, 2024

Cingulate secures capital ahead of 2025 plans to submit drug for FDA approval - The Business Journals

Dec 24, 2024

Dec 24, 2024

Cingulate Inc Secures $5M Financing for Strategic Growth - Yahoo Finance

Dec 24, 2024

Dec 23, 2024

Cingulate Inc. announced that it has received $5 million in funding - Marketscreener.com

Dec 23, 2024

Dec 23, 2024

Cingulate Completes Financing Transaction for Net Proceeds of $5,000,000 - GlobeNewswire

Dec 23, 2024

Dec 23, 2024

Cingulate Secures $5M Financing Deal to Advance CTx-1301 Drug Development Through 2025 - StockTitan

Dec 23, 2024

Nov 23, 2024

Cingulate (NASDAQ:CING) Upgraded at Maxim Group - Defense World

Nov 23, 2024

Nov 11, 2024

U.S. Stock market top gainers: Binah Capital Group gains +107.02%, Aligos Therapeutics surges by 42.84% in mid day trading - Business Upturn

Nov 11, 2024

Nov 11, 2024

Cingulate Inc. Announces Third Quarter Financial Results and Clinical Update - Defense World

Nov 11, 2024

Nov 07, 2024

Cingulate Inc (CING) Quarterly 10-Q Report - Quartz

Nov 07, 2024

Nov 07, 2024

CINGCingulate Inc. Latest Stock News & Market Updates - StockTitan

Nov 07, 2024

Nov 07, 2024

Cingulate reports Q3 net loss $3.2M vs. $5.98M last year - TipRanks

Nov 07, 2024

Nov 07, 2024

Cingulate Reports Third Quarter 2024 Financial - GlobeNewswire

Nov 07, 2024

Nov 07, 2024

Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market - StockTitan

Nov 07, 2024

Oct 09, 2024

Cingulate's Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show - The Manila Times

Oct 09, 2024

Oct 08, 2024

Cingulate’s Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show - GlobeNewswire

Oct 08, 2024

Oct 07, 2024

Cingulate secures funding to extend operations into Q2 2025 By Investing.com - Investing.com South Africa

Oct 07, 2024

Oct 07, 2024

SEC Form 424B3 filed by Cingulate Inc. - Quantisnow

Oct 07, 2024

Oct 07, 2024

Cingulate secures funding to extend operations into Q2 2025 - Investing.com India

Oct 07, 2024

Oct 07, 2024

Cingulate Inc Files for 1.5M Share Offering by Selling Stockholders - Investing.com Canada

Oct 07, 2024

Oct 05, 2024

Cingulate Inc. CEO faces domestic battery charge - Investing.com India

Oct 05, 2024

Oct 04, 2024

Cingulate Inc. CEO faces domestic battery charge By Investing.com - Investing.com South Africa

Oct 04, 2024

Sep 30, 2024

KC-area public company CEO faces charges for aggravated domestic battery - The Business Journals

Sep 30, 2024

Sep 28, 2024

Cingulate files to sell 1.5M shares of common stock for holders - MSN

Sep 28, 2024

Sep 24, 2024

Will Ciena's New 1.6 Tb/s Coherent Pluggable Solution Drive Top Line? - Zacks Investment Research

Sep 24, 2024

Sep 24, 2024

Concentrix Corp (CNXC) Q3 2024: Everything You Need to Know Ahea - GuruFocus.com

Sep 24, 2024

Sep 24, 2024

Cettire shares skyrocket - Finance News Network

Sep 24, 2024

Sep 24, 2024

Cettire gets auditor’s tick of approval, adding $247m to valuation - The Australian Financial Review

Sep 24, 2024

Sep 24, 2024

Stock of the day: Cettire - IG

Sep 24, 2024

Sep 23, 2024

Ciena Stock Goes to Buy From Sell at Citi. Here’s Why. - Barron's

Sep 23, 2024

Sep 23, 2024

Why Ciena Stock Popped 5% on Monday - The Motley Fool

Sep 23, 2024

Sep 23, 2024

Double-Upgrade Pushes Ciena Stock Near Record Highs - Schaeffers Research

Sep 23, 2024

Sep 23, 2024

Citi upgrades Ciena, shares rise in pre-market trade By Investing.com - Investing.com Canada

Sep 23, 2024

Sep 23, 2024

9 Analysts Assess Ciena: What You Need To Know - Benzinga

Sep 23, 2024

Sep 23, 2024

Ciena Unveils 1.6 Tb/s Coherent Pluggable Solution for Hyperscale Cloud Providers' Capacity Surge - Marketscreener.com

Sep 23, 2024

Sep 23, 2024

Ciena's stock rises after Citi double upgrades to Buy (NYSE:CIEN) - Seeking Alpha

Sep 23, 2024

Sep 23, 2024

Citi sees growth potential for Ciena stock as inventory challenges ease - Investing.com Australia

Sep 23, 2024